The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Glutamatergic targets for new alcohol medications
Open accessAbstract
Rationale An increasingly compelling literature points to a major role for the glutamate system in mediating the effects of alcohol on behavior and the pathophysiology of alcoholism. Preclinical studies indicate that glutamate signaling mediates certain aspects of ethanol's intoxicating and rewarding effects, and undergoes adaptations following chronic alcohol exposure that may contribute to the withdrawal, craving and compulsive drug-seeking that drive alcohol abuse and alcoholism.Objectives We discuss the potential for targeting the glutamate system as a novel pharmacotherapeutic approach to treating alcohol use disorders, focusing on five major components of the glutamate system: the N-methyl-D-aspartate (NMDA) receptor and specific NMDA subunits, the glycineB site on the NMDA receptors (NMDAR), L-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid ionotropic (AMPA) and kainate (KAR) receptors, metabotropic receptors (mGluR), and glutamate transporters.Results Chronic alcohol abuse produces a hyperglutamatergic state, characterized by elevated extracellular glutamate and altered glutamate receptors and transporters. Pharmacologically manipulating glutamatergic neurotransmission alters alcohol-related behaviors including intoxication, withdrawal, and alcohol-seeking, in rodents and human subjects. Blocking NMDA and AMPA receptors reduces alcohol consumption in rodents, but side-effects may limit this as a therapeutic approach. Selectively targeting NMDA and AMPA receptor subunits (e.g., GluN2B, GluA3), or the NMDAR glycineB site offers an alternative approach. Blocking mGluR5 potently affects various alcohol-related behaviors in rodents, and mGluR2/3 agonism also suppresses alcohol consumption. Finally, glutamate transporter upregulation may mitigate behavioral and neurotoxic sequelae of excess glutamate caused by alcohol.Conclusions Despite the many challenges that remain, targeting the glutamate system offers genuine promise for developing new treatments for alcoholism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies established a causal role for reduced prefrontal metabotropic glutamate receptor 2 (mGluR2) function in craving and relapse responses in preclinical models of alcohol dependence [48–52].”
From Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial (2024) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Ethanol Inhibits NMDA-Activated Ion Current in Hippocampal Neurons
Lovinger, D. M., White, G., & Weight, F. F. (1989) · Science · doi:10.1126/science.2467382 · Cited by 1,448
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
Drug Addiction as a Pathology of Staged Neuroplasticity
Kalivas, P. W., & O’Brien, C. P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301564 · Cited by 761
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Schoepp, D. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 693
Cited by
Sorted by citations
Items 101–197 of 197
NMDA receptor GluN2A subunit deletion protects against dependence-like ethanol drinking
Jury, N. J., Radke, A. K., Pati, D., Kocharian, A., Mishina, M., Kash, T. L., & Holmes, A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.06.029 · Cited by 13
Self-citationThe Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile
Vengeliene, V., Möller, A., Meinhardt, M. W., Beardsley, P. M., Sommer, W. H., Spanagel, R., & Bespalov, A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.225 · Cited by 12
Self-citationHuang, M., Tu, H.-Y., Chung, R., Kuo, H., Liu, T., Chen, C., Mochly‐Rosen, D., & Liu, Y. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01635-5 · Cited by 12
Laukkanen, V., Kärkkäinen, O. K., Kupila, J., Kautiainen, H., Tiihonen, J., & Storvik, M. (2014) · Alcohol and Alcoholism · doi:10.1093/alcalc/agu081 · Cited by 11
Vrettou, M., Nilsson, K. W., Tuvblad, C., Rehn, M., Åslund, C., Andershed, A., Wallén‐Mackenzie, Å., Andershed, H., Hodgins, S., Nylander, I., et al. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01293-w · Cited by 12
Gruol, D. L., Melkonian, C., Ly, K., Sisouvanthong, J., Tan, Y., & Roberts, A. J. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.06.043 · Cited by 10
Neurobiology of Alcohol Dependence and Implications on Treatment
Eşel, E., & Dinc, K. (2016) · Turkish Journal of Psychiatry · doi:10.5080/u14894 · Cited by 12
Ueno, F., Suzuki, T., Nakajima, S., Matsushita, S., Mimura, M., Miyazaki, T., Takahashi, T., & Uchida, H. (2019) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12058 · Cited by 10
Giacometti, L. L., & Barker, J. M. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146390 · Cited by 9
GABA and Glutamate Synaptic Coadaptations to Chronic Ethanol in the Striatum
Carlson, V. C. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_98 · Cited by 10
Nest, D. S. V., Hernandez, N. S., Kranzler, H. R., Pierce, R. C., & Schmidt, H. D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.050 · Cited by 9
Hoffman, J. L., Faccidomo, S., Taylor, S. M., DeMiceli, K. G., May, A. M., Smith, E. N., Whindleton, C. M., & Hodge, C. W. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06365-z · Cited by 6
Galduróz, J. C. F., Bezerra, A. G., Pires, G. N., Pauluci, R., & Noto, A. R. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200128120729 · Cited by 10
Laukkanen, V., Kärkkäinen, O. K., Kautiainen, H., Tiihonen, J., & Storvik, M. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.04.002 · Cited by 9
Beggiato, S., Borelli, A. C., Tomasini, M. C., Castelli, M. P., Pintori, N., Cacciaglia, R., Loche, A., & Ferraro, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00327 · Cited by 8
Translational approach to understanding momentary factors associated with alcohol consumption
Vengeliene, V., Foo, J. C., & Kim, J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15180 · Cited by 8
CCL2-ethanol interactions and hippocampal synaptic protein expression in a transgenic mouse model
Gruol, D. L., Vo, K., Bray, J. G., & Roberts, A. J. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00029 · Cited by 8
Amaral, V. C. S., Morais‐Silva, G., Laverde, C. F., & Marin, M. T. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.07.002 · Cited by 8
Bosse, K. E., Oginsky, M. F., Susick, L. L., Ramalingam, S., Ferrario, C. R., & Conti, A. C. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242321 · Cited by 7
Faccidomo, S., Saunders, B. L., May, A. M., Eastman, V. R., Kim, M. H., Taylor, S. M., Hoffman, J. L., McElligott, Z. A., & Hodge, C. W. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06740-4 · Cited by 7
Laukkanen, V., Kärkkäinen, O., Kautiainen, H., Tiihonen, J., & Storvik, M. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12791 · Cited by 8
Vrettou, M., Yan, L., Nilsson, K. W., Wallén‐Mackenzie, Å., Nylander, I., & Comasco, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-94739-8 · Cited by 8
Huang, G., Thompson, S. L., & Taylor, J. R. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14576 · Cited by 7
Alcohol use disorder-associated pain: clinical and preclinical evidence
Dong, Y., Buczynski, M. W., & Gregus, A. M. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.08.005 · Cited by 7
Effects of ethanol on GluN1/GluN2A and GluN1/GluN2B NMDA receptor‐ion channel gating kinetics
Peoples, R. W., & Ren, H. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14965 · Cited by 6
Libarino-Santos, M., Brandão, N. M. R., Borges, A. L. N., Anjos-Santos, A., Cata-Preta, E. G., Barros-Santos, T., Oliveira-Campos, D., Brito, A. C., Oliveira, T. S., Kisaki, N. D., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108520 · Cited by 5
Joo, Y., Kim, J., Kim, H.-K., Son, Y., Cumming, P. D., & Kim, J. (2021) · Life · doi:10.3390/life11060506 · Cited by 6
Gyetvai, B. M., & Vadász, C. (2025) · Biomolecules · doi:10.3390/biom15030392 · Cited by 5
Kim, D. J., Jeong, H., Kim, S. Y., Kim, Y. H., & Yim, H. W. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06883-4 · Cited by 7
Колик, Л. Г., Надорова, А. В., & Середенин, С. Б. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3946-0 · Cited by 5
Salling, M. C., Grassetti, A., Ferrera, V. P., Martinez, D., & Foltin, R. W. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173227 · Cited by 5
Patel, K. T., Stevens, M. C. G., Dunlap, A., Gallagher, A., O’Malley, S. S., DeMartini, K. S., Potenza, M. N., Krystal, J. H., & Pearlson, G. D. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01157-5 · Cited by 5
Self-citationLainiola, M., Hietala, L., Linden, A.-M., & Aitta‐aho, T. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119844178 · Cited by 5
Ethanol-Induced Changes in Brain of Transgenic Mice Overexpressing DYRK1A
Fructuoso, M., Gu, Y. C., Kassis, N., de Lagrán, M. M., Dierssen, M., & Janel, N. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01967-6 · Cited by 5
Ballesta, A., Alén, F., Orío, L., Arco, R., Vadas, E., Decara, J. M., Vargas, A., de Heras, R. G., Ramírez‐López, M., Serrano, A., et al. (2020) · Addiction Biology · doi:10.1111/adb.12957 · Cited by 5
Isla, E. M., Gutiérrez-Vega, I., Quilaqueo, M. E., Herrera-Marschitz, M., Quintanilla, M. E., Morales, P., Pérez-Reytor, D., Rivera‐Meza, M., & Karahanian, E. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1792426 · Cited by 4
Bennett, A., Kim, H., Thomas, D., Biggs, P., Ara, R., Bosomtwi, A., & Kang, S. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02264-3 · Cited by 4
Astrocyte Function in Alcohol Reward and Addiction
Adermark, L. (2015) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000e123 · Cited by 4
Tyler, R. E., Voorhies, K. J. V., Blough, B. E., Landavazo, A., & Besheer, J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173767 · Cited by 4
Clinical Treatment of Addictive Disorders with N-Acetylcysteine
Powell, G. L., McClure, E. A., Olive, M. F., & Gipson, C. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-5311-5_13 · Cited by 4
Hoffman, J. L., Faccidomo, S., Taylor, S. M., DeMiceli, K. G., May, A. M., Smith, E. N., Whindleton, C. M., & Hodge, C. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.14.520457 · Cited by 4
Kim, S. E., Joo, Y., Son, Y., Kim, H.-K., Lee, S., Lee, M., Ido, T., & Kim, J. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02094-7 · Cited by 3
From consumption to withdrawal: A broad synopsis of the effects of alcohol
Zhu, J., Liu, Q., Kong, B., Shuai, W., Xiao, Z., Dai, C., & Huang, H. (2023) · Medicine Advances · doi:10.1002/med4.46 · Cited by 4
Role of Glutamate Transport in Alcohol Withdrawal
Abulseoud, O. A., Ruby, C. L., & Karpyak, V. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00043-2 · Cited by 3
Alshehri, F. S. (2023) · Medicina · doi:10.3390/medicina59061101 · Cited by 3
Nashed, M. G., Chatterjee, D., Nguyen, D., Oleinichenko, D., Diwan, M., & Nóbrega, J. N. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05324-x · Cited by 3
Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants
Thompson, S. L., Gianessi, C. A., O’Malley, S. S., Cavallo, D. A., Shi, J. M., Tetrault, J. M., DeMartini, K. S., Gueorguieva, R. V., Pittman, B. P., Krystal, J. H., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.709559 · Cited by 3
Self-citationFaccidomo, S., Hoffman, J. L., Lee, J., Whindleton, C. M., Kim, M. H., Taylor, S. M., Kim, A., Richter, C., Seiters, H. L., Bryant, J., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06848-1 · Cited by 2
Sodium Bicarbonate Decreases Alcohol Consumption in Mice
Lin, J. C., Rivadeneira, A., Ye, Y., Ryu, C., Parvin, S., Jang, K., Garraway, S. M., & Choi, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095006 · Cited by 2
Bases neurobiologiques des traitements de l’alcoolo-dépendance – Quelles perspectives ?
Hamon, M. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2014.09.411 · Cited by 2
Internet Gaming Disorder Treatment Options in the Hospital Setting
Park, J. H., Hyun, G. J., Son, J. H., & Lee, Y. S. (2015) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2015.26.2.75 · Cited by 2
Improving Treatment, Prevention, and Rehabilitation
Gäebel, W., Riesbeck, M., Siegert, A., Zäske, H., & Zielasek, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-27839-1_30 · Cited by 2
Genetic Markers of Alcohol Use Disorder
Dasgupta, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800339-8.00010-9 · Cited by 2
Test for association of common variants in GRM7 with alcohol consumption
Melroy-Greif, W. E., Vadász, C., Kamens, H. M., McQueen, M. B., Corley, R. P., Stallings, M. C., Hopfer, C. J., Krauter, K. S., Brown, S. A., Hewitt, J. K., et al. (2016) · Alcohol · doi:10.1016/j.alcohol.2015.10.005 · Cited by 2
Oral glutamate intake reduces acute and chronic effects of ethanol in rodents
Supawat, A., Srisuwan, S., & Sattayasai, J. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i7.20 · Cited by 2
Alcohol and Central Glutamate Activity: What Goes Up Must Come Down?
Bell, R. L., Sari, Y., & Rahman, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813125-1.00047-7 · Cited by 2
Tobore, T. O. (2020) · Aggression and Violent Behavior · doi:10.1016/j.avb.2020.101378 · Cited by 2
New glutamatergic target for alcohol and substance use disorder medications
Vadász, C., & Saito, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3496-3 · Cited by 1
Role of Basal Forebrain in Nicotine Alcohol Co-abuse
Sharma, R., Sahota, P. K., & Thakkar, M. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805373-7.00027-x · Cited by 1
Laere, K. V., & Ceccarini, J. (2018) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000307 · Cited by 1
Graw, J. (2020) · Springer eBooks · doi:10.1007/978-3-662-60909-5_14 · Cited by 1
Miller, E. M. (2014) · UKnowledge (University of Kentucky) · Cited by 1
Faccidomo, S., Saunders, B. L., May, A. M., Eastman, V. R., Kim, M., Taylor, S. M., Hoffman, J. L., McElligott, Z. A., & Hodge, C. W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.13.612946 · Cited by 1
Graw, J. (2015) · Springer eBooks · doi:10.1007/978-3-662-44817-5_14
Lutz, J. A. (2014) · UKnowledge (University of Kentucky)
Karlsson, C. (2015) · Figshare
Momeni, S. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Gene Expression in Alcoholism: An Overview
Ghazali, R. F., & Patel, V. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00018-5
Neuropathology of Gene Expression during Alcohol Withdrawal
Aujla, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00049-3
N-Methyl-d-Aspartate Receptor Subunits and Alcohol
Nona, C. N., & Nóbrega, J. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00046-8
The Roots and Individual Diversity of Addiction
Leis, A. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420190-3.00031-4
Glutamatergic mechanisms in behavioural sensitization to ethanol
Nona, C. N. (2016) · TSpace (University of Toronto)
Neuropeptide Receptors as Treatment Targets in Alcohol Use Disorders
Aziz, A. M. A. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-139884
A common molecular mechanism for cognitive deficits and craving in alcoholismPreprint
Meinhardt, M. W., Pfarr, S., Rohleder, C., Vengeliene, V., Barroso-Flores, J., Hoffmann, R., Meinhardt, M. L., Paul, E. R., Hansson, A. C., Köhr, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.13.200519
Self-citationFaccidomo, S., Cogan, E. S., Hon, O. J., Hoffman, J. L., Saunders, B. L., Eastman, V. R., Kim, M. H., Taylor, S. M., McElligott, Z. A., & Hodge, C. W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.25.436994
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.002
Do MTHFR C677T Genetic Polymorphism Influence in the Pathogenesis of Amyotrophic Lateral Sclerosis?Preprint
Azevedo, R. M., Santos, K. D. F., de Oliveira, R. P. D., Pereira, J. C., Bento, D. D. C. P., Reis, Â. A. D. S., & Santos, R. D. S. (2021) · Research Square · doi:10.21203/rs.3.rs-939291/v1
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.003
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3829237/v1
Tomasini, M. C., Loche, A., Cacciaglia, R., Ferraro, L., & Beggiato, S. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00632-2
Raval, N. R., Smart, K. A., Miller, R., Huang, Y. H., Krystal, J. H., Carson, R. E., Cosgrove, K., O’Malley, S. S., & Hillmer, A. T. (2024) · Research Square · doi:10.21203/rs.3.rs-5183167/v1
Self-citationPuhakka, E., Ahmed, H., Haikonen, R., Leclercq, S., Hanhineva, K., Maccioni, L., Amadieu, C., Lehtonen, M., Männistö, V., Rysä, J., et al. (2024) · medRxiv · doi:10.1101/2024.12.10.24318756
Use of antiepileptic drugs in mental disorders
Martsenkovsky, I., Martsenkovska, I. I., & Makarenko, H. V. (2025) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.20.8.2024.1129
TARP ɣ-8 is a target of ethanol that regulates self-administration and relapse in micePreprint
Faccidomo, S., Hoffman, J. L., Lee, J., Whindleton, C. M., Kim, M. H., Taylor, S. M., Kim, A., Richter, C., Seiters, H. L., Bryant, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.27.645788
Raval, N. R., Smart, K. A., Angarita, G. A., Miller, R., Huang, Y. H., Krystal, J. H., Carson, R. E., Cosgrove, K., O’Malley, S. S., & Hillmer, A. T. (2025) · Addiction Biology · doi:10.1111/adb.70031
Self-citationFellbaum, C. M., McKee, J. L., Zhao, Y., Harris, J. M., Padua, D., Katti, R., Mitra, T., Levahn, J. G., Katti, P., Ren, H., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70107
Integrative Approaches to Treatment and Recovery of Substance Use Disorders (SUD)
Mostafa, S. A., Elemary, E. A., Allam, R. A., & El-Fattah, N. A. A. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1414-4_22
Sonsini, G., & Marchant, N. J. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02300-2
Ehrenhofer‐Murray, A. E. (2025) · Springer eBooks · doi:10.1007/978-3-662-70328-1_14
Leroy, A., Valentin, A., Sautreuil, C., Carpentier, G., Racine, C., Lecointre, M., Janin, F., Vivien, D., Marret, S., Picaud, S. A., et al. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.1419-25.2026
Modrak, C. G., Holstein, S. E., Kim, A., Shannon, E. G., Faccidomo, S., Besheer, J., & Hodge, C. W. (2026) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70409
Goutaudier, R. (2022) · theses.fr (ABES) · doi:10.70675/6619b466z54bfz41e3z8a90zf0967825d579
Băluțoiu, I., Dinescu, S. N., Greșiță, A., Radu, L., Taisescu, C. I., Rotaru-Zăvăleanu, A. D., Aldea, M., Ruscu, M. A., Teică, R. V., Zorilă, M. V., et al. (2026) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.67.1.01
Chronic Alcohol Exposure Alters Expression of GluN3A-NMDA Receptors in Adult VTA DA NeuronsPreprint
Yang, K., Shaw, J. K., Dani, J. A., & Biasi, M. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.08.750197
Martsenkovsky, I., Shum, S. S., Martsenkovska, I. I., Makarenko, H. V., & Vashchenko, O. S. (2026) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.22.4.2026.1244
Johnston, C. J., & Thompson, S. L. (2026) · Alcohol · doi:10.1016/j.alcohol.2026.09.007
Metadata
- Authors
- Holmes, A., Spanagel, R., & Krystal, J. H.
- Affiliations
- National Institutes of Health (US)
- Heidelberg University (DE)
- Yale University (US)
- Corresponding author
- Holmes, Andrew
- Venue
- Psychopharmacology
- Published
- 2013-09-01
- Volume
- 229
- Issue
- 3
- Pages
- 539-554
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC3811052
- OpenAlex
- W2104412023
- Cited by
- 197
- References
- 221
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 5 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 15 · 2018: 22 · 2017: 14 · 2016: 25 · 2015: 29 · 2014: 17 · 2013: 1
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (P50AA012870, ZIAAA000411)
- National Center for Research Resources (UL1RR024139)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- glutamatergic system, alcoholism, alcoholism pharmacotherapy, NMDA receptor, NMDA receptor glycine site, AMPA receptors, kainate receptors, metabotropic glutamate receptors, mGluR5, glutamate transporters, GluN2B, GluA3, alcohol withdrawal, alcohol craving, alcohol seeking, chronic ethanol exposure, glutamate excitotoxicity
- MeSH terms
- Alcoholism, Animals, Humans, Substance Withdrawal Syndrome, Receptors, N-Methyl-D-Aspartate, Receptors, AMPA, Kainic Acid Receptors, Glutamic Acid, Protein Subunits, Molecular Targeted Therapy, Drug-Seeking Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review